Mark S. Smyczynski is an Assistant Professor in the Department of Radiology at UMass Chan Medical School. His work focuses on nuclear medicine imaging, particularly SPECT and 4D-CT techniques, with an emphasis on respiratory motion correction and lesion detection. Education: BS in Physics (University of Illinois), MD (Chicago Medical School), PhD in Medical Physics (Wayne State University) Affiliations: UMass Chan Medical School; T.H. Chan School of Medicine Research Interests: His research explores the intersection of medical physics and radiology, addressing technical challenges in: Respiratory motion modeling for improved imaging accuracy Iterative reconstruction algorithms in SPECT imaging Mediastinal lesion detection Cardiac motion analysis 4D-CT dataset processing Data standardization for translational science Publication Trends: His work spans 2007–2022, with a focus on nuclear medicine physics, pulmonary imaging, and optimization of diagnostic systems. Key collaborations include researchers like Michael King and Thomas FitzGerald. Technical Networks: Associated with concepts like Gallium Radioisotopes Mediastinal Neoplasms Tomography (SPECT) Computer-Assisted Image Processing Variance Analysis
Professor Ramon Vilar Compte is Professor of Medicinal Inorganic Chemistry at Imperial College London 's Department of Chemistry within the Faculty of Natural Sciences . His multidisciplinary research group develops molecular tools for biological interrogation. Key affiliations include: CRUK Convergence Science Centre , Centre for Neurotechnology , Centre for Rapid Online Analysis of Reactions , and Grantham Institute Research focuses on: Medicinal Inorganic Chemistry of G-quadruplex DNA/RNA Metal complexes for cancer and antibacterial therapies Environmental remediation of toxic metals via molecular recognition Advanced optical imaging techniques using fluorescence/phosphorescence lifetime Recent publications demonstrate expertise in metal-based G-quadruplex probes , photocytotoxic antibiotics , and machine learning-driven drug discovery . Group members include 9 PhD students and 5 postdoctoral associates working across chemical biology and environmental science domains.
Professor James Stone is a leading academic psychiatrist and neuroscientist at Brighton and Sussex Medical School, University of Sussex. He holds the position of Professor of Psychiatry (Clinical Neuroscience) and maintains an active research and clinical profile, with a focus on the neurobiological basis of psychiatric disorders. His work integrates neuroimaging, psychopharmacology, and clinical trials to develop novel treatments and biomarkers for conditions such as schizophrenia, depression, and bipolar disorder. Institution: University of Sussex School: Brighton and Sussex Medical School Academic Rank: Professor Email: bsms9kkf@sussex.ac.uk Education: BSc (1st Hons) in Neuroscience, University of London (1994) MBBS, University of London (1997) PhD, University of London (2008) MRCPsych, Royal College of Psychiatrists (2001) CCT in General Adult Psychiatry (2005) FRCPsych (2015) Dr Stone’s research interests center on the role of glutamate and GABA in psychosis and depression, the early-stage testing of novel treatments (including ketamine, probiotics, and binaural beats), and the development of neuroimaging biomarkers to enable stratified medicine in psychiatry. He investigates the biological mechanisms of ketamine in treatment-resistant depression, GABA modulation in psychosis, and the gut microbiota’s role in mood disorders. Additional projects explore inflammation in mental illness, glucose metabolism in schizophrenia, brain connectivity in chronic ketamine users, and auditory neuromodulation. His recent publications reflect a strong trend in translational neuroscience, with a focus on glutamatergic and GABAergic systems, neuroinflammation, gut-brain interactions, and digital or non-invasive interventions. Articles span high-impact journals such as JAMA Psychiatry , Molecular Psychiatry , and Translational Psychiatry , demonstrating rigorous clinical and neurochemical methodologies. Key themes include probiotic adjuncts in depression, ketamine mechanisms, binaural beats, and multimodal neuroimaging in psychosis. Scientific Awards and Recognition: No formal awards listed in the provided text. Professor Stone actively supervises PhD students and has secured substantial research funding from major bodies including the Medical Research Council (MRC), National Institute for Health Research (NIHR), and Wellcome Trust. His grants support innovative work on stroboscopic light therapy, electronic health record-based risk prediction, probiotics for depression, and neurobiological mechanisms in schizophrenia and psychosis. He also contributes to academic leadership through committee roles in the British Association of Psychopharmacology and the RCPsych Academic Faculty Executive Committee. Labs and Research Teams: While specific lab names are not mentioned, Dr Stone leads a multidisciplinary research group focused on clinical neuroscience and experimental psychiatry. His team includes collaborators from King’s College London, Imperial College, and the Maudsley Hospital, and he has established the ketamine clinic at the Maudsley, underscoring his translational impact. His current projects involve extensive collaboration across neuroscience, psychiatry, and data science, particularly in using natural language processing of electronic health records for early intervention in severe mental illness.
Dr. Tobias Bauer, MD, BSc, is a postdoctoral researcher and assistant physician at the University of Bonn, affiliated with the Department of Neuroradiology and the Clinic and Polyclinic for Epileptology. He is a member of the Translational Neuroimaging Working Group led by PD Dr. med. Theodor Rüber, under the directorship of Prof. Dr. med. Alexander Radbruch and Prof. Dr. med. Rainer Surges. His work bridges clinical practice and advanced neuroimaging research, focusing on autoimmune encephalitis and epilepsy. University: University of Bonn School: Medical Faculty Department: Department of Neuroradiology Position: Researcher Email: tobias.bauer@ukbonn.de Dr. Bauer studied nautical science at Wismar University, mathematics at FernUniversität Hagen, and human medicine at the University of Bonn, where he earned his doctorate on structural connectivity in limbic encephalitis. His research focuses on image-guided phenotyping of autoimmune encephalitis using 7T MRI and data-driven modeling. He aims to develop clinically relevant biomarkers for improved diagnosis and treatment planning in both adults and children. The recent publications highlight a strong trend in computational neuroimaging, machine learning for lesion detection, and multimodal MRI analysis in epilepsy. His work spans from fundamental brain connectivity studies to translational applications, including portable MRI and AI benchmarks. This reflects a cohesive research program integrating clinical neurology, advanced imaging, and data science. Scientific awards include: Merit Award, Organization for Human Brain Mapping (2022) Medical Excellence Award, Manfred-Lautenschläger-Foundation (2021) BONFOR SciMed Grant (2019) Cusanuswerk Scholarship (2019) BonnNI Structured MD Program (2018) Dr. Bauer has been supported by multiple grants and is actively involved in national and international collaborations. He supervises no students explicitly mentioned, but contributes to a vibrant research environment in the Translational Neuroimaging Group. His lab focuses on developing imaging biomarkers and disease models in autoimmune encephalitis, leveraging ultrahigh-field MRI and computational tools.
Samuel Svensson is an Adjunct Professor at Linköping University's Department of Physics, Chemistry and Biology (IFM). His research focuses on neurodegenerative diseases, advanced imaging techniques (PET/SPECT), and biomarker development. Key areas include tauopathies, Parkinsonian syndromes, and melanoma imaging. He collaborates internationally on radiotracer development and neuroimaging applications. Recent work includes groundbreaking studies on 4R-tauopathies and corticobasal syndrome diagnostics. He also contributed to UAV-based 3D terrain reconstruction research, showcasing interdisciplinary interests. Education details are not explicitly provided in available texts. His academic career includes sustained contributions to neuroscience and biomedical imaging from 2015 to present. Awards and grants remain unspecified in the provided information.
Letterio Salvatore Politi is a Full Professor at Humanitas University, where he serves as Director of the School of Specialization in Diagnostic Radiology and Chair of the Master's Degree in Data Analytics and Artificial Intelligence in Health Sciences (DAIHS). He holds significant international roles as Director of Clinical Affairs at the Advanced MR Imaging Center (AMRIC), University of Massachusetts Medical School, and Director of Neuroimaging Research in the Division of Hematology/Oncology and Radiology Department at Boston Children’s Hospital. His research focuses on advanced magnetic resonance imaging (MRI) for non-invasive quantification of neurological disease burden. Key areas include quantitative MRI of the brain and spinal cord , lesion load and volumetric analyses , and microstructural damage assessment via diffusion tensor imaging across a spectrum of neurological conditions such as brain tumors, vascular diseases, neuromuscular disorders, and inherited neurodegenerative diseases. Dr. Politi has authored 67 peer-reviewed scientific publications with an h-index of 26 and over 3,300 citations (Scopus), contributing significantly to translational and clinical neuroimaging. His work includes validating MRI-based outcome measures for clinical trials, central radiological review in international multicenter studies, and the development of integrated multimodal imaging systems like SPECT/MRI. Although specific articles are not listed, his research output demonstrates a consistent focus on imaging biomarkers and advanced neuroimaging methodologies. Full Professor, Humanitas University Director, School of Specialization in Diagnostic Radiology Chair, Master’s in Data Analytics and AI in Health Sciences (DAIHS) Director of Clinical Affairs, AMRIC, UMass Medical School Director of Neuroimaging Research, Boston Children’s Hospital Dr. Politi plays a vital role in mentoring and academic leadership through his directorship of residency and master’s programs. While specific grants or funded projects are not detailed, his leadership in core imaging facilities and international trials suggests active grant involvement and research oversight. He is instrumental in advancing clinical MRI research and training the next generation of radiologists and data scientists in health. He leads neuroimaging research initiatives at Boston Children’s Hospital and directs clinical affairs at the Advanced MR Imaging Center (AMRIC), a core imaging facility at UMass, fostering innovation in imaging technology and its clinical application.
Dr. Craig Abbey is a Researcher at the University of California, Santa Barbara (UCSB), affiliated with the Vision and Image Understanding Lab. His work focuses on optimizing medical image analysis through mathematical modeling of human visual perception and engineering parameters like image processing algorithms. He held prior roles including Assistant Professor at UC Davis Biomedical Engineering and postdoctoral fellowships in Medical Physics. Abbey’s research integrates computational models with experimental psychophysics to improve medical imaging applications, particularly in breast cancer screening and CT/SPECT imaging. Educations: PhD in Applied Mathematics (University of Arizona, 1998) Research interests center on how visual tasks (e.g., lesion detection) are influenced by image noise textures, display engineering, and visual adaptation effects. He explores AI-driven tools for enhancing radiologist performance and developing anthropomorphic model observers that replicate human visual search strategies in 3D medical imaging. Recent work addresses sequential reading effects in mammography, non-Gaussian noise properties in CT, and deep learning-based denoising techniques for SPECT/CT. His studies highlight practical applications like optimizing screening protocols and improving diagnostic accuracy through adaptive image ordering. Labs/Teams: Vision and Image Understanding Lab at UCSB.
Zubin Bhagwagar is a faculty member at the Yale School of Medicine , affiliated with the Department of Psychiatry . He holds the academic rank of Professor and has contributed extensively to research in neuropsychopharmacology, neuroimaging, and psychiatric disorders. Education : MBBS, MD, FRCPsych, DPhil His research interests span Major Depressive Disorder , Bipolar Disorder , Neurotransmitter Systems , Mitochondrial Genetics , and Alzheimer's Disease . He has published seminal work on serotonin receptors , ketamine effects , and neurochemical imaging in psychiatric conditions. Dr. Bhagwagar’s recent studies focus on lumateperone for treating depression and bipolar disorder with anxious distress. His work also includes clinical trial methodologies , drug safety assessments , and neurochemical biomarkers in mood disorders. He has collaborated on interdisciplinary projects involving mitochondrial gene expression , neuroimaging , and pharmacogenomics , though no specific scientific awards or student advisement details are mentioned in the provided texts.
Anthony McGoron is a Professor and Undergraduate Program Director in the Department of Biomedical Engineering at Florida International University. His research focuses on molecular imaging, drug delivery systems, and image-guided therapies. Current projects include developing radiopharmaceuticals for cancer diagnosis/therapy, 3D cell culture models for treatment evaluation, and AI-driven medical imaging analysis tools. Research interests span nuclear medicine (PET/SPECT), bioengineering of nanoparticles, and extracellular vesicle biology. Notable innovations include a novel 3D liver segmentation algorithm for radiation therapy planning and chitosan-based microspheres for dual diagnostic/therapeutic applications. His work bridges molecular biology with clinical translation, addressing challenges in targeted cancer therapy and treatment efficacy assessment. Developed FLT/PET imaging protocols for pancreatic tumor proliferation analysis Pioneered BRAF/RAS mutation-based thyroid cancer theranostics Created FDA-compliant biodegradable microspheres for radiation therapy Recent studies emphasize organoid models for EV research and SIRT treatment optimization through quantitative perfusion imaging. His lab maintains active collaborations in both basic science and clinical applications.
Durval Costa is a Principal Investigator at the Champalimaud Foundation , leading the Durval Costa Lab within the Nuclear Medicine - Radiopharmacology department. His research focuses on radiopharmaceutical development , quantitative imaging analysis , and radiation dosimetry for oncology and neuropsychiatry applications. Key Research Areas: SPECT/PET imaging, tumor phenotyping, personalized radiotherapy dosimetry, and computational analysis of functional abnormalities Collaborative Expertise: Integrates physics, mathematics, and clinical nuclear medicine Recent Publications (2023-2025) highlight his work on deep learning in lesion segmentation , interhemispheric brain asymmetry in dementia , and standardization of digital/analog PET/CT scanners . Collaborations span oncology, neurology, and metabolic imaging domains. Lab Team includes nuclear medicine physicians, mathematicians, physicists, and technicians working on: Developing MC simulation-based dosimetry Optimizing 18F-florbetaben for amyloid imaging Validating EARL1-compliant PET reconstruction protocols Investigating PSMA expression in thyroid pathology
Zbisław Tabor is a Professor and Deputy Head of the Department of Biocybernetics and Biomedical Engineering within the Faculty of Electrical Engineering, Automatics, Computer Science and Biomedical Engineering at AGH University of Science and Technology in Kraków, Poland. His office is located in building C-2, room 411 (4th floor), with contact phone +48 12 617 46 60 and email ztabor@agh.edu.pl. He also serves on the Biomedical Engineering Discipline Council, contributing to academic governance in his field. Professor Tabor's research spans the critical intersection of biomedical engineering and artificial intelligence, with emphasis on medical image analysis and clinical decision support systems . His work focuses on: Advanced medical image segmentation using deep learning architectures (e.g., nnU-Net) Uncertainty quantification in AI-driven diagnostic tools Quantitative imaging for radiation therapy planning and monitoring Computer-aided diagnosis systems for oncology and cardiology Improving reliability of medical image annotation through computational methods Analysis of his recent publications (2022-2025) reveals a strong trajectory toward clinically applicable AI solutions. Key trends include the development of automated body composition analysis for cancer prognosis, SPECT/CT imaging protocols for targeted alpha therapy of brain tumors, and robust deep learning frameworks for wound assessment and cardiomegaly screening. His research consistently addresses multi-center validation and real-world implementation challenges in medical AI. No scientific awards are documented in the available information. There is no mention of student advising, research grants, or laboratory facilities in the provided materials.
Eduardo Fernández-Megía is a Full Professor of Organic Chemistry at the University of Santiago de Compostela (USC), affiliated with the Center for Research in Biological Chemistry and Molecular Materials (CiQUS). He holds a PhD from USC (supervised by Prof. F. J. Sardina) and completed postdoctoral research at the University of Cambridge under Prof. Steven V. Ley (1997–1999). His career includes roles as a Marie Curie Fellow, Associate Professor, and Ramon y Cajal Fellow before attaining his current professorship in 2010. His research bridges chemical biology and polymer science, emphasizing: Design of dendrimers and polymeric nanostructures for drug delivery, diagnostics (MRI/PET/SPECT), and biomedical applications Polymer synthesis, nanoassembly characterization, and in vitro/in vivo evaluation Click-chemistry protocols for stimuli-responsive biomaterials Multivalent functionalization of proteins/ligands to modulate biological interactions NMR methodology development (rapid spectroscopy, polymer dynamics, spectral purification) Notable recognitions include: Marie Curie Fellowship Ramon y Cajal Fellowship
Prof. Nathalie Ginovart is a leading academic at the University of Geneva , affiliated with the Department of Psychiatry and Department of Basic Neurosciences . Her research focuses on understanding how behavioral traits like impulsivity, novelty seeking, and risky decision-making interact with dysregulation in the mesocorticolimbic dopamine system to predispose individuals to addictive disorders (substance and behavioral). She employs a cross-species translational approach, integrating behavioral testing, in vivo molecular imaging (PET/SPECT), and pharmacogenetic tools in rodent models. Education: Not explicitly stated in the provided text. Affiliations: University of Geneva, Switzerland. Research Interests revolve around addiction mechanisms, dopamine receptor dynamics, and neural circuitry in impulsive behavior. Her lab investigates baseline and drug-induced changes in dopaminergic signaling, cross-species behavioral paradigms (e.g., rat Gambling Task), and receptor occupancy studies. Recent work examines how cocaine self-administration alters dopamine D2/3 receptor availability and amphetamine-induced release in relation to impulsivity. Publication Trends (2024–2019) span neuroscience, neuropsychopharmacology, and neuroimaging. Key areas include dopamine receptor subtypes (D1/D2/D3), cocaine addiction models, serotonin transporter imaging, impulsive action vs. risk-related decision-making, and computational methods for PET/SPECT data. Lab Members: Raphael Goutaudier (Postdoc) Florian Gilhet-Marchessaux (PhD Student) Laura Rodriguez Peris (PhD Student)
Ann Van Eeckhaut is a Professor in the Department of Pharmaceutical and Pharmacological Sciences at the Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel. With an h-index of 25 and over 2681 citations, she leads significant research in neuropharmacological analysis methods, specializing in the development of miniaturized liquid chromatography techniques for neurotransmitter and drug analysis in biological samples. Her research expertise spans: Neurochemical and neuropharmacological analysis requiring sensitive methods for low-concentration compounds Development of miniaturized LC methods coupled to fluorescence, electrochemical, and MS/MS detection Quantification of neuropeptides in microdialysis samples using Nano LC-MS/MS Metabolite profiling for biomarker discovery in drug-resistant epilepsy Enantioselective analysis of neuro- and gliotransmitters Recent publications demonstrate her leadership in advancing analytical techniques for brain metabolomics, with increasing focus on 3D printing for sample preparation devices and natural compounds for neurodegenerative disease treatment. Her work bridges analytical chemistry, neuroscience, and translational pharmacology, with particular emphasis on Parkinson's and Alzheimer's disease therapies. Scientific recognition includes: Project grant from Wetenschappelijk Fonds Willy Gepts (WFWG) in December 2021 for epilepsy biomarker research Dr. Van Eeckhaut actively supervises graduate research with 31 theses completed under her guidance. She leads multiple significant research projects including FWOSB173 (2024-2028) on ADHD medication during pregnancy, FWOAL1076 (2023-2026) on brain metabolomics, and VLIR418 (2022-2027) on levodopa-rich biomass for neurodegenerative diseases. Her research group maintains extensive collaboration networks across neuroscience and analytical chemistry disciplines. Her laboratory specializes in developing cutting-edge analytical methods for neurochemical analysis, with particular focus on volume-limited samples and high-throughput requirements for modern pharmacological research.
Chiti Arturo is a Full Professor in the Department of Imaging and Radiotherapy at the School of Medicine, Vita-Salute San Raffaele University, Milan, Italy. He serves as a doctoral advisor in the Molecular and Experimental Medicine program at Humanitas University for cycles 31-38 (2015-2022) and teaches Master's-level courses in Health Informatics ("Images in healthcare - radiomics") and undergraduate Radiobiology. His research spans critical areas of: Nuclear Medicine Radiology Oncology Molecular Imaging Radiotherapy Medical Imaging Recent publications reveal a pronounced focus on PET imaging innovations for cancer management, including motion correction in pediatric brain tumor studies, PSMA-based prostate cancer staging, and radiomic modeling for pancreatic adenocarcinoma. His work consistently addresses clinical validation of imaging biomarkers through multi-center trials, emphasizing quantitative analysis for treatment response assessment and nodal metastasis detection. With over 200 publications, Professor Arturo demonstrates sustained leadership in translating advanced imaging techniques—particularly PET/MRI and radioembolization dosimetry—into oncology applications, significantly contributing to protocol standardization in molecular imaging.
